// App-Quantinova.ai

: Extrafine beclometasone dipropionate, formoterol fumarate, glycopyrronium (BDP/FF/G) and exacerbation recurrence: post-hoc analysis of the TRIBUTE study.

Researchers

Presenter

  • Leonardo Fabbri

Principal Investigators

  • Dave Singh

  • Jorgen Vestbo

  • Massimo Corradi

  • Alessandro Guasconi

  • Mario Scuri

  • George Georges

  • Isabella Montagna

  • Hlne Prunier

  • Stefano Vezzoli

  • Stefano Petruzzelli

  • Alberto Papi

Medical Centers

  • Department of medecine (University), Ferrara, Italy

  • Medicines Evaluation Unit, Manchester, United Kingdom.

  • Division of infection, immunity and Respiratory medecine (university), Manchester, United Kingdom

  • Department of medecine and surgery (university), Parma, Italy

  • Chiesi Farmaceutici, S.p.A, Parma, Italy,

  • Research centre on asthma and COPD, Ferrara, Italy

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • beclometasone dipropionate

  • Formoterol

  • Seebri Breezhaler

  • beclometasone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved